practicing physicans. Second, individual letters were sent to more than 300 primary care physicians in areas where previous case reports originated. Finally, serologic testing for antibodies to the Lyme spirochete was offered free of charge to any practitioner submitting sera from patients with suspected LD.
Information on reported cases was collected on a form which elicited demographic information, tick exposure histories, and symptoms associated with the disease.
For the purposes of this study, we defined a case as any person reported by a physician to have Lyme disease with symptoms beginning in 1982 and who had at least one of the following disease manifestations: erythema chronicum migrans (ECM), aseptic meningitis (fever, headache, and stiff neck), facial nerve palsy, and/or large joint arthritis. Serologic Assay Stock cultures of the I. dammini spirochete maintained in modified Kelly's medium [5] were fixed to the wells of microtiter slides in a method previously described [4] . Sera from persons with suspected LD were tested in pairs when two or more specimens were obtained, or singly when one specimen was available. Both positive and negative control specimens were tested simultaneously. Indirect immunofluorescence was performed using fluorescein isothiocyanate-(FITC) labeled goat anti-human IgG serum (Cappel Laboratories, Cochranville, PA). Sera reactive at 2 1:16 were titered to endpoint dilution.
Control Sera
As control sera, we utilized specimens obtained for premarital syphilis screening from 329 persons who lived in two upstate counties, located more than 200 miles from any area known to be endemic for LD. All specimens were submitted to the New York State Department of Health Laboratories between July and September 1982. None were reactive when tested by automated reagin test (ART). Clinical histories of LD or other illnesses on these patients were not known.
Analysis of Data
Data from case report forms and serologic results were computerized. Data from seropositive and seronegative persons were compared, using Pearson's chi-square contingency test. This comparison was conducted twice. Seropositives were first defined as persons with convalescent sera collected more than two weeks after first symptoms of LD with titers 2 64. These cases were compared with seronegative persons having convalescent titers < 64. Seropositives were defined in the second comparison as persons with titers 2 256, who were again compared to seronegative persons with titers < 64.
Persons with paired sera who demonstrated a fourfold rise in IgG antibody titer were also compared to persons with paired sera demonstrating no fourfold rise and no single titer 2 64. In this comparison, the acute serum specimen was required to be collected within two weeks of symptom onset.
Each case was given a clinical index score ranging from 0-25, based upon their reported symptoms. Index scores were derived from the presence of the following symptoms: ECM (10 points), fever (2) , aseptic meningitis (3) , large joint arthritis (5), facial palsy (3) , and palpitations (2) . Index scores were compared for seropositive and seronegative cases.
RESULTS
During 1982, 207 cases of LD meeting the case definition were reported. Cases ranged in age from one to 79 years, with a mean age of 28 years. Forty-eight percent were men, and 52 percent were women. Cases were reported from 11 upstate counties and New York City, but 84 percent were residents of either Suffolk (56 percent) or Westchester (28 percent) counties (Fig. 1) (Fig. 2) . In the 156 cases who had at least one serum specimen collected and who reported a precise date of onset, symptoms began in every month except February and March. Again, however, 101 (65 percent) had symptoms beginning in June, July, or August (Fig. 2) .
Forty-six (23 percent) of 201 cases reported hospitalization as a result of LD. Length of stay ranged from 1-21 days, with a mean of 7.5 days. Antibiotic treatment was reported to have been given to 169 (82 percent) of 205 cases. Most frequently administered antibiotic therapy was penicillin (72.5 percent), followed by tetracycline (14.4 percent) and erythromycin (2.4 percent Wherever it occurs, LD appears to be highly focal in its distribution. New York cases occurring in 1982 also followed this pattern, being clustered in two areas: the south shore and eastern forks of Long Island, and parts of northern Westchester County. Both areas share several features which contribute to the substantial incidence of LD: they have plentiful deer populations, they are endemic areas for Ixodes dammini ticks, and they have sufficient population densities to allow humans to serve as alternate tick hosts with some frequency. While other areas of New York have greater deer population density, L dammini does not occur in areas farther north and west, accounting for the absence of cases reported from these areas.
The case definition we employed in this surveillance study was not as rigid as that required by the CDC and utilized in previous case series. Specifically, ECM was not required for inclusion in our case count. We purposely employed a less stringent case definition for two reasons. First, some cases of LD may occur without ECM, or where this sign is not recognized. We sought to quantitate the proportion of cases which were suspected by physicians on clinical grounds to be LD, who had signs or symptoms associated with the disease, but did not [8, 9] . However, myalgias (72 percent) and facial palsy (18 percent) occurred more frequently in our cases. The higher proportion of persons with facial palsy is in part due to inclusion of persons with palsy but without recognized ECM. Nonetheless, 21 (13.5 percent) of 155 persons with ECM reported palsy, a figure still substantially higher than previous reports [8, 10] . Thirty (88 percent) of 34 persons with palsy had either ECM, a fourfold titer rise, or a single titer > 128, suggesting that 17 percent of our cases demonstrated this sign even when a stricter case definition is used.
Large joint swelling developed in 31 percent of patients, which is consistent with the 35-43 percent of patients treated with antibiotics who developed arthritis in previous reports [10, 11] . Overall, more than 80 percent of our cases received antibiotic therapy. The significant association between persons with reactive sera and tick bite and/or symptoms beginning in June, July, and August may imply that caes reported during these months are more likely to have LD. Previous reports have established that nymphal Ixodes dammini are the tick stage most frequently found during these three months [12] , and that this stage is commonly infected with the Lyme spirochete [13] . Data 
